Formation Bio appoints Michael Ehlers as chief scientific officer and head of R&D
Formation Bio has hired Michael Ehlers to lead its scientific and research operations as chief scientific officer and head of R&D.
The biotech firm announced that Michael Ehlers will serve as its chief scientific officer and oversee research and development. Ehlers previously founded and ran Ascidian Therapeutics as chief executive officer and president. The move aims to strengthen Formation Bio's scientific leadership. No further details on his responsibilities were provided.
Why it matters
The hire could enhance Formation Bio's research capacity and influence its future biotech developments.
In this story
Michael EhlersFormation Biochief scientific officerresearch and developmentAscidian Therapeuticshiringbiotechleadership
